Enhancing effects of immunoactive peptide FR48217 on immunological responses to vaccination by inactivated influenza virus
- 1 August 1989
- Vol. 7 (4), 351-356
- https://doi.org/10.1016/0264-410x(89)90201-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antiviral effect of two aryl-oligopeptides, FR41565 and FR48217Antiviral Research, 1986
- Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in JapanThe Journal of Infectious Diseases, 1986
- ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTIONThe Lancet, 1984
- Hemolysis by Liposomes Containing Influenza Virus HemagglutininsJournal of Virology, 1983
- Potentiation of the Immune Response to Influenza Virus Subunit VaccinesThe Journal of Immunology, 1977
- Purification of Sendai Virions with Glutaraldehyde-Treated Red Blood CellsIntervirology, 1977
- Inactivated Influenza Vaccine Efficacy: Diminished Antigenicity of Split-Product Vaccines in MiceInfection and Immunity, 1974
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycansNature, 1974
- Adjuvant Properties of Bacterial Cell Wall MucopeptidesThe Journal of Immunology, 1966